Primary Hyperlipidemia and Mixed DyslipidemiaDrug TrialsShow entriesDrugDrug NamePhaseStatusCount DB01076 Atorvastatin 3 Completed 1 DB09303 Evolocumab 3 Completed 1 Showing 1 to 2 of 2 entries ‹ 1 › Stay up-to-date with the latest from DrugBank! Subscribe Downloads Data Library Academic...
and J. Moon, "Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia," Expert Review of Cardiovascular Therapy, vol. 8, no. 8, pp. 1079-1090, 2010.Gotto AM,Moon J.Pitavasta tin for the treatment ofprimary hyperlipidemia and mixed dyslipidemia. Ex-pert Rev Cardiovasc...
[Reproducibility of fasting serum cholesterol and triglycerides in ambulatory patients with mixed hyperlipidemia]Intraindividual variability of serum lipid concentrations in normal volunteers and in patients with hyperlipidemia is substantial. The ... B Martina,M Weinbacher,S Kiener,... - 《Schweiz Med ...
These effects are pointing out that PS-HOSO may serve as a functional ingredient for metabolic syndrome or diabetic sufferers, which not only influences body weight, but also prevents or reverses insulin resistance and hyperlipidemia.Background Metabolic syndrome represents a cluster of metabolic ...
A total of 304 patients with mixed hyperlipidemia were randomized to receive CoA 400 U/d plus statin or placebo plus statin (n = 152, each group). After treatment for 8 weeks, the mean percent change in TG was significantly greater with CoA plus statin compared with placebo plus statin...